Dana Investment Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
387,867
+100,143
+35% +$4.23M 0.32% 66
2026
Q1
$15.9M Sell
287,724
-40,952
-12% -$1.95M 0.47% 44
2025
Q4
$12.3M Sell
328,676
-26,409
-7% -$1.07M 0.36% 59
2025
Q3
$14.4M Sell
355,085
-37,794
-10% -$1.25M 0.42% 53
2025
Q2
$10M Sell
392,879
-6,126
-2% -$134K 0.33% 66
2025
Q1
$8.52M Sell
399,005
-10,286
-3% -$230K 0.31% 74
2024
Q4
$8.6M Sell
409,291
-50,532
-11% -$1.17M 0.28% 80
2024
Q3
$10.4M Sell
459,823
-54,103
-11% -$1.04M 0.34% 69
2024
Q2
$8.62M Buy
513,926
+75,546
+17% +$1.21M 0.29% 92
2024
Q1
$5.67M Buy
+438,380
New +$5.25M 0.19% 149
2019
Q1
Sell
-6,330
Closed -$204K 297
2018
Q4
$204K Hold
6,330
0.01% 266
2018
Q3
$272K Sell
6,330
-746
-11% -$35.2K 0.01% 252
2018
Q2
$326K Hold
7,076
0.01% 243
2018
Q1
$281K Buy
+7,076
New +$262K 0.01% 248

Other funds holding PAHC

Dana Investment Advisors's PAHC Position: Q2 2026 in Review

Dana Investment Advisors increased its Phibro Animal Health (PAHC) stake by 35% in Q2 2026, buying an estimated $4.23M and bringing the position to 387,867 shares worth $12.2M. The position accounts for 0.32% of the portfolio, ranked #66.

Dana Investment Advisors first reported a position in PAHC in Q1 2018 and has held it in 14 quarters since. The position peaked at $15.9M in Q1 2026. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Dana Investment Advisors held 387,867 shares of Phibro Animal Health worth $12.2M as of Q2 2026.
  • Dana Investment Advisors bought 100,143 Phibro Animal Health shares in Q2 2026, an estimated $4.23M.
  • Phibro Animal Health made up 0.32% of Dana Investment Advisors's portfolio in Q2 2026, its #66 holding.
  • Dana Investment Advisors first reported a position in Phibro Animal Health in Q1 2018 and has held it in 14 quarters since.
  • Dana Investment Advisors's Phibro Animal Health position peaked at $15.9M in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.